Aldolases, nucleic acids encoding them and methods for making and using them

Patent metadata

Field	Value
Publication number	US-9719079-B2
Application number	US-201615009414-A
Country	US
Kind code	B2
Filing date	Jan 28, 2016
Priority date	Mar 7, 2006
Publication date	Aug 1, 2017
Grant date	Aug 1, 2017

Abstract

This invention relates to polypeptides having aldolase activity, including pyruvate activity such as, without limitation, HMG and/or KHG aldolase activity, polynucleotides encoding these polypeptides, and methods of making and using these polynucleotides and polypeptides. In some embodiments, the invention is directed to polypeptides having aldolase activity, including pyruvate activity such as, without limitation, HMG and/or KHG aldolase activity, including thermostable and thermotolerant activity, and polynucleotides encoding these enzymes, and making and using these polynucleotides and polypeptides. The polypeptides in accordance with the invention can be used in a variety of pharmaceutical, agricultural and industrial contexts. In some embodiments, the invention provides polypeptides and biosynthetic pathways that are useful in the production of R-2-hydroxy 2-(indol-3ylmethyl)-4-keto glutaric acid (R-MP) and certain stereoisomers of monatin, such as R,R and S,R monatin, and salts thereof, as well as certain stereoisomers of monatin derivatives, such as the R,R and S,R configurations, and salts thereof.

First claim

What is claimed is:

1. An isolated, synthetic or recombinant nucleic acid that encodes a polypeptide having aldolase activity, wherein the nucleic acid is selected from the group consisting of:
(a) a nucleic acid encoding at least one polypeptide, wherein the nucleic acid comprises a sequence having 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, or 99%, sequence identity to the sequence of SEQ ID NO: 243, wherein the nucleic acid encodes the polypeptide having an aldolase activity; and
(b) a nucleic acid encoding the polypeptide having an aldolase activity, wherein the polypeptide comprises a sequence 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, or 99% sequence identity to the sequence of SEQ ID NO: 244, and enzymatically active fragments thereof.

2. The isolated, synthetic or recombinant nucleic acid of claim 1 , wherein the aldolase activity comprises a pyruvate aldolase activity.

3. The isolated, synthetic or recombinant nucleic acid of claim 1 , wherein the aldolase activity comprises a HMG aldolase activity.

4. The isolated, synthetic or recombinant nucleic acid of claim 1 , wherein the aldolase activity comprises a KHG aldolase activity.

5. An expression cassette, a vector or a cloning vehicle comprising a nucleic acid comprising the nucleic acid of claim 1 , wherein optionally the cloning vehicle comprises a viral vector, a plasmid, a phage, a phagemid, a cosmid, a fosmid, a bacteriophage or an artificial chromosome.

6. The cloning vehicle of claim 5 , wherein the viral vector comprises an adenovirus vector, a retroviral vector or an adeno-associated viral vector, or, the artificial chromosome comprises a bacterial artificial chromosome (BAC), a bacteriophage P1-derived vector (PAC), a yeast artificial chromosome (YAC), or a mammalian artificial chromosome (MAC).

7. A transformed cell comprising the nucleic acid of claim 1 wherein optionally the cell is a bacterial cell, a mammalian cell, a fungal cell, a yeast cell, an insect cell, or a plant cell.

8. A method of producing the recombinant polypeptide having aldolase activity comprising the steps of:
(a) providing the nucleic acid of claim 1 operably linked to a promoter; and
(b) expressing the nucleic acid of step (a) under conditions that allow expression of the polypeptide, thereby producing recombinant polypeptide having aldolase activity,
wherein optionally the method further comprises transforming a host cell with the nucleic acid of step (a) followed by expressing the nucleic acid of step (a), thereby producing a recombinant polypeptide in a transformed cell.

9. The nucleic acid of claim 1 encoding the polypeptide having an aldolase activity, wherein the polypeptide is lacking a signal sequence.

10. The nucleic acid of claim 1 , encoding a polypeptide having an aldolase activity and further comprising a heterologous sequence.

11. The nucleic acid of claim 10 , wherein the heterologous sequence is a tag, an epitope, a targeting peptide, a cleavable sequence, a detectable moiety, or a polypeptide that does not have aldolase activity.

Assignees

• Basf Enzymes Llc

Inventors

• Weiner David P
• Zhao Lishan
• Luginbuhl Peter
• Burke Ellen
• Richardson Toby H
• Hicks Paula M

Classifications

• A61P43/00

  Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00 · CPC title

• A61P35/00

  Antineoplastic agents · CPC title

• A61P31/04

  Antibacterial agents · CPC title

• C12Y401/03016

  4-Hydroxy-2-oxoglutarate aldolase (4.1.3.16) · CPC title

• A01K2217/05

  Animals comprising random inserted nucleic acids (transgenic) · CPC title